loading

Latigo Biotherapeutics, Inc. Common Stock Azioni (LTGO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30
Durata del periodo 3 mesi
Operating Expenses
Operating Income/Loss
Nonoperating Income/Loss
Income Tax Expense/Benefit
Net Income/Loss
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
$7.06
price down icon 5.11%
$7.21
price down icon 2.96%
$24.80
price down icon 3.73%
$18.15
price down icon 1.31%
$3.13
price down icon 4.86%
$10.38
price down icon 2.90%
Capitalizzazione:     |  Volume (24 ore):